Cardiac resynchronization therapy device
Citation, DOI, disclosures and case data
At the time the case was submitted for publication Callum Smith had no recorded disclosures.View Callum Smith's current disclosures
Mixed ischemic and non-ischemic cardiomyopathy
Cardiac resynchronization therapy (CRT) device in situ (right atrial, right ventricular and coronary sinus leads). An insulated right ventricular lead indicates that this is a CRT defibrillator device. The cardiac silhouette is enlarged. There is no confluent consolidation.
Cardiac resynchronisation therapy (CRT) is indicated in patients with heart failure (moderate to severe), systolic dysfunction (left ventricular ejection fraction <35%) and prolonged QRS duration despite being treated with appropriate pharmacotherapy. CRT works through simultaneous pacing of the right and left ventricles. The goal of CRT is to improve the patient's left ventricular dyssynchrony which is largely secondary to a left bundle branch block. CRT devices may also have defibrillator capacity 1-2.
- 1. Leclercq C & Hare J. Ventricular Resynchronization: Current State of the Art. Circulation. 2004;109(3):296-9. doi:10.1161/01.CIR.0000113458.76455.03 - Pubmed
- 2. Bristow M, Saxon L, Boehmer J et al. Cardiac-Resynchronization Therapy with or Without an Implantable Defibrillator in Advanced Chronic Heart Failure. N Engl J Med. 2004;350(21):2140-50. doi:10.1056/NEJMoa032423 - Pubmed